Free Trial

Rep. David Taylor Buys Procter & Gamble Company (The) (NYSE:PG) Shares

Procter & Gamble logo with Consumer Staples background

Key Points

  • Representative David Taylor purchased between $1,001 and $15,000 in shares of Procter & Gamble (NYSE:PG) on August 7th, as indicated in a filing disclosed on September 2nd.
  • Procter & Gamble reported a quarterly earnings per share (EPS) of $1.48, exceeding analyst expectations of $1.42, with a revenue of $20.89 billion, up 1.7% from the previous year.
  • The company set its FY 2026 guidance EPS at a range of 6.830-7.090, and currently has a dividend yield of 2.7% with an annualized dividend of $4.23.
  • Five stocks to consider instead of Procter & Gamble.

Representative David Taylor (R-Ohio) recently bought shares of Procter & Gamble Company (The) (NYSE:PG). In a filing disclosed on September 02nd, the Representative disclosed that they had bought between $1,001 and $15,000 in Procter & Gamble stock on August 7th. The trade occurred in the Representative's "DAVID TAYLOR TRUST > SCHWAB JOINT BROKERAGE #1 (HOME GROWN)" account.

Representative David Taylor also recently made the following trade(s):

  • Purchased $1,001 - $15,000 in shares of Eli Lilly and Company NYSE: LLY on 8/14/2025.
  • Purchased $1,001 - $15,000 in shares of Marathon Petroleum NYSE: MPC on 8/14/2025.
  • Purchased $15,001 - $50,000 in shares of Eli Lilly and Company NYSE: LLY on 8/14/2025.
  • Purchased $1,001 - $15,000 in shares of Prologis NYSE: PLD on 8/14/2025.
  • Purchased $1,001 - $15,000 in shares of Visa NYSE: V on 8/13/2025.
  • Purchased $1,001 - $15,000 in shares of Procter & Gamble NYSE: PG on 8/13/2025.
  • Sold $1,001 - $15,000 in shares of Installed Building Products NYSE: IBP on 8/13/2025.
  • Purchased $1,001 - $15,000 in shares of Salesforce NYSE: CRM on 8/7/2025.
  • Purchased $1,001 - $15,000 in shares of Prologis NYSE: PLD on 8/7/2025.
  • Purchased $1,001 - $15,000 in shares of Vertex Pharmaceuticals NASDAQ: VRTX on 8/7/2025.

Procter & Gamble Trading Up 0.6%

NYSE:PG traded up $0.89 on Friday, reaching $160.08. The company's stock had a trading volume of 6,435,480 shares, compared to its average volume of 8,024,406. Procter & Gamble Company has a 12-month low of $149.91 and a 12-month high of $180.43. The company has a quick ratio of 0.49, a current ratio of 0.70 and a debt-to-equity ratio of 0.49. The firm has a market cap of $374.65 billion, a price-to-earnings ratio of 24.59, a price-to-earnings-growth ratio of 4.17 and a beta of 0.36. The stock has a 50 day moving average price of $156.41 and a 200 day moving average price of $162.31.

Procter & Gamble (NYSE:PG - Get Free Report) last issued its quarterly earnings data on Tuesday, July 29th. The company reported $1.48 earnings per share for the quarter, beating analysts' consensus estimates of $1.42 by $0.06. Procter & Gamble had a return on equity of 32.69% and a net margin of 18.95%.The business had revenue of $20.89 billion during the quarter, compared to analysts' expectations of $20.79 billion. During the same period in the previous year, the firm posted $1.40 earnings per share. The company's revenue was up 1.7% on a year-over-year basis. Procter & Gamble has set its FY 2026 guidance at 6.830-7.090 EPS. On average, equities analysts anticipate that Procter & Gamble Company will post 6.91 EPS for the current fiscal year.

Procter & Gamble Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Friday, August 15th. Investors of record on Friday, July 18th were issued a $1.0568 dividend. This represents a $4.23 annualized dividend and a dividend yield of 2.6%. The ex-dividend date of this dividend was Friday, July 18th. Procter & Gamble's dividend payout ratio (DPR) is currently 64.98%.

Insider Activity at Procter & Gamble

In other news, CFO Andre Schulten sold 11,638 shares of the business's stock in a transaction dated Tuesday, August 19th. The shares were sold at an average price of $157.27, for a total transaction of $1,830,308.26. Following the transaction, the chief financial officer directly owned 52,642 shares in the company, valued at $8,279,007.34. The trade was a 18.11% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, insider Marc S. Pritchard sold 9,849 shares of the company's stock in a transaction dated Tuesday, August 19th. The shares were sold at an average price of $157.27, for a total transaction of $1,548,952.23. Following the completion of the transaction, the insider owned 182,422 shares in the company, valued at approximately $28,689,507.94. This trade represents a 5.12% decrease in their position. The disclosure for this sale can be found here. Insiders sold 120,181 shares of company stock worth $18,918,012 over the last ninety days. Company insiders own 0.18% of the company's stock.

Analysts Set New Price Targets

PG has been the subject of several analyst reports. UBS Group set a $180.00 price objective on Procter & Gamble and gave the company a "buy" rating in a research note on Wednesday, July 30th. Wells Fargo & Company decreased their price objective on Procter & Gamble from $175.00 to $173.00 and set an "overweight" rating on the stock in a report on Wednesday, July 30th. Barclays set a $164.00 target price on Procter & Gamble and gave the stock an "equal weight" rating in a research report on Thursday, July 31st. JPMorgan Chase & Co. restated a "neutral" rating and set a $170.00 target price (down from $178.00) on shares of Procter & Gamble in a research note on Friday, July 25th. Finally, Evercore ISI reiterated an "in-line" rating and issued a $170.00 price target (down from $190.00) on shares of Procter & Gamble in a research note on Monday, July 14th. One research analyst has rated the stock with a Strong Buy rating, ten have issued a Buy rating and seven have assigned a Hold rating to the company. According to data from MarketBeat, the company currently has a consensus rating of "Moderate Buy" and a consensus target price of $175.12.

Read Our Latest Analysis on Procter & Gamble

Hedge Funds Weigh In On Procter & Gamble

A number of large investors have recently modified their holdings of the stock. Cladis Investment Advisory LLC increased its stake in Procter & Gamble by 5.2% in the 4th quarter. Cladis Investment Advisory LLC now owns 4,807 shares of the company's stock valued at $806,000 after buying an additional 236 shares during the last quarter. Benjamin Edwards Inc. increased its stake in shares of Procter & Gamble by 120.7% during the 1st quarter. Benjamin Edwards Inc. now owns 364,378 shares of the company's stock worth $62,098,000 after purchasing an additional 199,258 shares during the last quarter. Capital Investment Advisory Services LLC increased its stake in shares of Procter & Gamble by 13.8% during the 1st quarter. Capital Investment Advisory Services LLC now owns 37,709 shares of the company's stock worth $6,426,000 after purchasing an additional 4,562 shares during the last quarter. World Investment Advisors increased its stake in shares of Procter & Gamble by 6.0% during the 1st quarter. World Investment Advisors now owns 50,913 shares of the company's stock worth $8,677,000 after purchasing an additional 2,886 shares during the last quarter. Finally, Concurrent Investment Advisors LLC increased its stake in shares of Procter & Gamble by 26.4% during the 1st quarter. Concurrent Investment Advisors LLC now owns 120,002 shares of the company's stock worth $20,451,000 after purchasing an additional 25,059 shares during the last quarter. 65.77% of the stock is currently owned by institutional investors and hedge funds.

About Representative Taylor

David Taylor (Republican Party) is a member of the U.S. House, representing Ohio's 2nd Congressional District. He assumed office on January 3, 2025. His current term ends on January 3, 2027. Taylor (Republican Party) ran for election to the U.S. House to represent Ohio's 2nd Congressional District. He won in the general election on November 5, 2024. David Taylor graduated from Amelia High School. Taylor earned degrees from Miami University (Ohio) and the University of Dayton School of Law. Taylor's career experience includes working as an attorney and as a businessman at Sardinia Ready Mix, Inc.

About Procter & Gamble

(Get Free Report)

Procter & Gamble Co engages in the provision of branded consumer packaged goods. It operates through the following segments: Beauty, Grooming, Health Care, Fabric and Home Care, and Baby, Feminine and Family Care. The Beauty segment offers hair, skin, and personal care. The Grooming segment consists of shave care like female and male blades and razors, pre and post shave products, and appliances.

Featured Stories

Should You Invest $1,000 in Procter & Gamble Right Now?

Before you consider Procter & Gamble, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Procter & Gamble wasn't on the list.

While Procter & Gamble currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The 10 Best AI Stocks to Own in 2025 Cover

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Not All AI Stocks Are Done — 4 With Huge Growth Ahead
The Quantum Race: 4 Companies Competing for the Future
September Rate Cuts: 3 Stocks Set to Benefit Most

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines